On October 11, the recall was classified as a class II recall by the FDA—a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health ...

Spravato, a depression treatment derived from club drug ketamine, was looking like a dud. Its recent success now shows a path ...

The reduction in dose could eliminate the need for liver function monitoring that has previously held back agomelatine’s ...

New, non-hallucinogenic versions of psychedelics are blurring the boundaries of the drug trip.

Vitamin B1, also known as thiamine, is crucial for the survival of cells; however, the human body is unable to produce it. To ...

It’s a physiological condition that is common and extreme and different from the postpartum challenges that are regularly ...

The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...

The Phase IIa study (NCT06235905) met its primary endpoint – showing a clinically meaningful improvement of -6.1 on the ...

The substances most frequently associated with these poisonings include over-the-counter antihistamines, prescription ...

Bupropion hydrochloride extended-release tablets are widely prescribed for the treatment of major depressive disorder and for ...

Recently, ketamine has gained popularity as a chemical compound. It has rapidly transitioned from a party drug to a potential ...

Miindfulness-based stress reduction may be as effective as escitalopram (Lexapro — an SSRI commonly used to treat depression ...